Scinovex
article Open AccessTop 1% cited

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

PLoS Medicine · 2012 · Vol. 9(5) · pp. e1001216–e1001216
Douglas G. AltmanLisa M. McShaneWilli SauerbreiSheila E. Taube

Abstract

The REMARK (Reporting Recommendations for Tumor Marker Prognostic Studies) guideline includes a checklist which aims to improve the reporting of these types of studies. Here, we expand on the REMARK checklist to enhance its use and effectiveness through better understanding of the intent of each item and why the information is important to report. Each checklist item of the REMARK guideline is explained in detail and accompanied by published examples of good reporting. The paper provides a comprehensive overview to educate on good reporting and provide a valuable reference of issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general.

Pancreatic and Hepatic Oncology ResearchRadiomics and Machine Learning in Medical ImagingLung Cancer Treatments and MutationsChecklistGuidelineMedicineMEDLINEElaborationMeta-analysisPsychologyPathologyBiologyCognitive psychology

MeSH terms

HumansNeoplasmsPrognosisPublishingResearch DesignBiomarkers, TumorGuidelines as TopicBiomedical ResearchChecklistResearch Report

Funding

  • Cancer Research UK
  • National Cancer Institute
Citations
1,021
FWCI
35.23
field-weighted impact
References
248
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.